Osteoprotegerin (OPG), human recombinant

Osteoprotegerin (OPG), human recombinant is available at Gentaur for Next week delivery.

A decoy receptor for RANKL

Biomolecule/Target: Osteoprotegerin

Alternates names: Osteoprotegerin, OPG, Tumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, TNFRSF11B, OCIF

Synonyms: Osteoprotegerin, OPG

Background Information: Human OPG (Osteoprotegerin), also known as OCIF (Osteoclastogenesis inhibitory factor), is a member of the TNF receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number. Recombinant human OPG is a 20 kDa protein, comprising of 174 amino acid residues.

Reconstitution Instructions: Reconstitute in 5 mM Tris, pH 7.5 to a concentration of 0.1-1.0 mg/ml. The solution can be diluted into other aqueous buffers and stored at 4°C for 1 week or –20°C for future use.

NCBI Gene Symbol: OPG

Gene ID: 8602

NCBI Accession: O14790